STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).

News

In 2021, We Need Your Support

Commit to being a contributor at any level.

October 15, 2021
NHIF Fellow Program
The application process for the 2022 class of NHIA Fellows is now open. Sponsored by IMS, the Fellow program seeks to advance the home and specialty infusion profession through practice, excellence, and leadership.

Application Deadline: Nov. 7, 2021

October 5, 2021
Transitional Benefit Did Not Boost DMEPOS Utilization In 2019
New publicly available data from the Centers for Medicare and Medicaid Services for CY 2019 shows that beneficiary utilization of the Part B DMEPOS home infusion benefit continued to decline despite the availability of the additional payment for nursing services under the transitional benefit.

September 14, 2021
NHIA and 20+ Organizations Sign Joint Letter To Congress To Support Home Infusion Legislation

NHIA submitted comments to the Centers for Medicare and Medicaid Services (CMS) on a proposed rule that outlined CY 2022 payment policies under the Physician Fee Schedule and other changes to Medicare Part B payment polices.

September 13, 2021
NHIA To Publish Scholarly Journal for Infusion Therapies
This new scholarly journal will feature independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.

September 8, 2021
NHIA and 20+ Organizations Sign Joint Letter To Congress To Support Home Infusion Legislation
On September 8, a group of stakeholders, including home infusion providers, patient advocacy groups, professional societies, and industry suppliers, sent a letter to leaders in the House of Representatives and the Senate encouraging them to pass the Preserving Patient Access to Home Infusion Act (S 2652; H.R. 5067).

August 27, 2021
NHIA Comments On Medicare Home Health Proposed Rule
NHIA has submitted comments to CMS on the CY 2022 Home Health Rule which outlines proposed coverage and policy changes for home infusion and other post-acute services.

August 23, 2021
NHIA Applauds House Introduction of Bipartisan Home Infusion Legislation
A companion bill to S.2652, The Preserving Patient Access to Home Infusion Act (H.R. 5067) — introduced in the House by Reps. Terri Sewell (D-AL), Debbie Dingell (D-MI), Fred Upton (R-MI), and Vern Buchannan (R-FL) — would ensure patients with serious viral and fungal infections, heart failure, immune diseases, cancer, and other conditions can receive the intravenous (IV) medications they need while at home.

August 5, 2021
Bipartisan Legislation Would Maintain Home Infusion Access Among Medicare Beneficiaries
The Preserving Patient Access to Home Infusion Act — introduced by Sen. Mark Warner (D-VA) and Sen. Tim Scott (R-SC) — would ensure patients with serious viral and fungal infections, heart failure, immune diseases, cancer, and other conditions can receive the intravenous (IV) medications they need while at home.

May 6, 2021
NHIA Releases Statement On CMS’ Medicare Payment Rate Increase for Monoclonal Antibody Treatments
NHIA has issued a statement on the decision made today by the Centers for Medicare & Medicaid Services (CMS) to increase the Medicare payment rate for administering monoclonal antibodies.

May 6, 2021
NHIA Named Recipient of ASAE 2021 Gold Circle Award for INFUSION Magazine
The National Home Infusion Association (NHIA) is pleased to be the recipient of an American Society of Association Executives (ASAE) 2021 Gold Circle Award for the association’s bi-monthly INFUSION print magazine, which underwent a redesign in 2019.

April 22, 2021
National Home Infusion Association Announces 2022 Annual Conference to be held in Nashville
NHIA has announced that their 2022 Annual Conference will be held on-site in Nashville, Tennessee, March 12-16, 2022. The conference is the premier event for the home and specialty infusion industry and will be held at the Gaylord Opryland Resort & Convention Center, just minutes away from downtown Nashville.

April 21, 2021
National Home Infusion Foundation announces recipient of 2021 Outstanding Abstract Achievement Award
NHIF is proud to announce that the recipient of the 2021 Outstanding Abstract Achievement Award (OAAA) is Christina Ritchey, MS, RD, LD, CNSC. The OAAA is awarded to an individual that presents a poster during the National Home Infusion Association’s (NHIA) Annual Conference on a relevant home and specialty infusion topic.

April 19, 2021
NHIF announces 2021 Lynn Giglione Women in Leadership Award recipient
NHIF  is proud to announce that Cindy Sumrall, RN, BSN, CRNI, IgCN is the recipient of the 2021 Lynn Giglione Women in Leadership Award. The Lynn Giglione Women in Leadership Award is given each year to recognize and honor trail-blazing and accomplished women leaders who have distinguished themselves within their organizations and among their industry peers.

April 19, 2021
NHIA Announces Recipient of 2021 Gene Graves Lifetime Achievement Award
NHIA is proud to announce that Varner R. Richards, PharmD is the recipient of the 2021 Gene Graves Lifetime Achievement Award. The Gene Graves Lifetime Achievement Award is the highest honor that NHIA bestows on a member of the home and specialty infusion community.

April 16, 2021
NHIA Submits Comments on Proposed EN and PN LCDs
On April 10, NHIA submitted written comments to the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) on proposed local coverage determinations (LCDs) for enteral nutrition (DL38955) and parenteral nutrition (DL38953). The association also provided oral comments in a public meeting held by the DME MACs in March.
Read NHIA’s EN comments | Read NHIA’s PN comments

February 9, 2021
NHIA Sends Letter to Biden Administration on Home & Specialty Infusion
Today, NHIA sent a letter to key members of the Biden administration, urging them to prioritize home-based care as the nation continues its recovery from COVID-19. In the letter, NHIA applauded the administration’s focus on health care and combatting the coronavirus, and outlined four policy recommendations related to the home and specialty infusion industry.

February 3, 2021
NHIA Offers Suggestions on MOU implementation to FDA, NABP
On February 1, NHIA sent a letter to the U.S. Food and Drug Administration (FDA) and the National Association of Boards of Pharmacy (NABP) offering suggestions to improve implementation of the Memorandum of Understanding (MOU) between the 2 entities. Specifically, NHIA encouraged: state boards of pharmacy to act expeditiously in determining whether or not they will enter into the MOU and make special efforts to communicate their intentions; states to give pharmacies at least 120 days’ notice; state boards of pharmacy and NABP to conduct regular stakeholder outreach; and NABP to create a compounding stakeholder information resource where information can be consolidated regarding the status of each state’s participation.

January 30, 2021
NHIA Submits Comments on Proposed Change of External Infusion Pump LCD
The National Home Infusion Association (NHIA) submitted comments on the proposed change of the External Infusion Pump LCD, adding coverage for chronic inflammatory demyelinating polyneuropathy (CIDP) as an approved indication for Hizentra.

January 15, 2021
NHIA Announces 16 Home Infusion Fellows in Program’s Inaugural Year
The National Home Infusion Association (NHIA) is pleased to announce the inaugural Fellow Program (FNHIA) cohort, made up of highly accomplished home and specialty infusion professionals. The program is administered and funded by the National Home Infusion Foundation (NHIF), thanks to a generous contribution from Integrated Medical Systems, Inc. (IMS), the 2021 sponsor of the NHIA Fellow Program.

January 13, 2021
NHIA Submits Comments on Termination of FDA’s Unapproved Drugs Initiative
NHIA has submitted comments to the Department of Health and Human Services (HHS) on the notice, “Termination of the Food and Drug Administration’s (FDA) Unapproved Drugs Initiative; Request for Information Regarding Drugs Potentially Generally Recognized as Safe and Effective”, which outlines the FDA’s decision to terminate the Unapproved Drugs Initiative (UDI).

January 12, 2021
Improving Access to COVID Vaccines for Homebound, Rural, and Vulnerable Populations
The National Home Infusion Association (NHIA) and National Association for Home Care and Hospice (NAHC) are urging the Department of Health and Human Services (HHS) and state health departments to ensure home infusion pharmacies are able to access vaccines and supply them either directly, or in collaboration with home health providers.

January 6, 2021
NHIA announces keynote for first-ever Global Congress on Home Infusion Therapy
The National Home Infusion Association (NHIA) will be hosting the first-ever Global Congress on Home Infusion Therapy (GCHIT) on April 19, 2021, and Daniel Kraft, MD, a health technology expert, will serve as the event’s keynote speaker. Held as a pre-conference to NHIA’s 2021 Annual Conference, the GCHIT offers an opportunity for home infusion clinicians and providers from across the world to share experiences, ideas, accomplishments, and challenges associated with the delivery of infused medications in the home setting.

December 22, 2020
NHIA Submits Comments on CMS’ DMEPOS Proposed Rule
NHIA has submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the proposed rule “Medicare Program; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Policy Issues and Level II of the Healthcare Common Procedure Coding System (HCPCS)”, published on November 4. The rule proposed new criteria for the definition of when an ambulatory infusion pump is “appropriate for use in the home”. NHIA members are encouraged to submit their own comments to CMS on this proposed rule. All comments are due by 5 p.m. on January 4, 2021.

December 11, 2020
MHA to Sponsor Creation of National Home Infusion Performance Standards
The National Home Infusion Association (NHIA) is pleased to announce that Managed Health Care Associates Inc. (MHA) is the 2021 sponsor for the National Home Infusion Foundation’s (NHIF) Benchmarking program whose goal is to establish national standards for patient satisfaction and clinical outcomes for home and specialty infusion.

November 2, 2020
NHIA to Host 2021 Annual Conference Virtually, April 19-22, 2021
In order to keep attendees and communities safe during the COVID-19 pandemic, NHIA has converted the 2021 Annual Conference – the premier conference for the home and specialty infusion industry – to a fully virtual event.

October 30, 2020
CMS Proposal Would Revise the DMEPOS External Infusion Pump Benefit
The National Home Infusion Association has been engaging with members and stakeholders regarding the impacts to home infusion from the Centers for Medicare and Medicaid Services (CMS) proposed rule: “Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Policy Issues and Level II of the Healthcare Common Procedures Coding System (HCPCS), CMS-1738-P.”

October 9, 2020
NHIA Commends CMS for Retiring Obsolete Parenteral and Enteral Nutrition LCDs
On October 8, 2020, a joint publication was released by the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) stating that the existing LCDs for PN and EN are being retired effective November 12, 2020, “due to the evolution of parenteral nutrition clinical paradigms.”

September 23, 2020
NHIA awards Congressman Engel for leadership on home infusion policy
The National Home Infusion Association (NHIA) has awarded Congressman Eliot Engel (D-NY) of New York’s 16th congressional district, with the 2020 Congressional Leadership Lifetime Achievement Award for his leadership on home infusion coverage for Medicare patients.

August 19, 2020
National Home Infusion Foundation Publishes Annual Rates of Patient Satisfaction with Home Infusion
The National Home Infusion Foundation (NHIF) has released results of an annual patient satisfaction study with home and specialty infusion in the study: 2019 Assessment of Home Infusion Patient Satisfaction.

August 18, 2020
National Home Infusion Association Submits Comments to CMS on “CY 2021 Home Health Prospective Payment System Rate Update”
The National Home Infusion Association (NHIA) has submitted comments to the Centers of Medicare & Medicaid Services (CMS) on “Medicare and Medicaid Programs; CY 2021 Home Health Prospective Payment System Rate Update; Home Health Quality Reporting Requirements; and Home Infusion Therapy Services Requirements”.

May 21, 2020
National Home Infusion Foundation announces recipient of 2020 Outstanding Abstract Achievement Award
The National Home Infusion Foundation (NHIF) is proud to announce that the winner of the 2020 Outstanding Abstract Achievement Award is Rachel Dellevar, PharmD.
Read the release.

May 11, 2020
NHIA Submits Comments to CMS on Interim Final Rule
The National Home Infusion Association (NHIA) submitted comments to CMS on the interim final rule with comment period: Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency.
Read the comments.

May 8, 2020
PTCB offering online proctored exam for PTCB credential exams
Beginning May 4, 2020, PTCB is offering online proctored exam delivery of all PTCB credential exams, including the Pharmacy Technician Certification Exam® (PTCE®), the Certified Compounded Sterile Preparation Technician® (CSPT®) Exam, Technician Product Verification Certificate (TPV) Exam, and Medication History Certificate Exam. 

May 8, 2020
National Home Infusion Association announces new members on board of directors
The National Home Infusion Association (NHIA) is proud to announce that Kathleen Patrick, John C. Rademacher, and Michael Zeglinski have joined the association’s Board of Directors.
Read the release.

April 29, 2020
National Home Infusion Foundation presents 2020 Lynn Giglione Women in Leadership Award
The National Home Infusion Foundation (NHIF) is proud to announce that Stacey Jensen, RN, BSN, MBA/HCM, is the recipient of its 2020 Lynn Giglione Women in Leadership Award.
Read the release

April 29, 2020
National Home Infusion Association presents 2020 Gene Graves Lifetime Achievement Award
The National Home Infusion Association (NHIA) is proud to announce that Lisa Sackuvich, RN, BSN, CRNI®, is the recipient of its 2020 Gene Graves Lifetime Achievement Award.
Read the release

April 24, 2020
National Home Infusion Foundation releases industry-defining Infusion Industry Trends report
Home and specialty infusion is a $19 billion industry serving more than 3.2 million patients annually, according to the National Home Infusion Foundation’s (NHIF) Infusion Industry Trends report.
Read the release

April 20, 2020 
Major Health Systems Ask CMS to Waive Home Infusion Restrictions; 160+ Stakeholders Endorse Legislative Remedy
Read the release
Read the waiver request

April 4, 2020 
CMS Interim Final Rule Falls Short for Home Infusion
The National Home Infusion Association (NHIA) has been engaging with members and stakeholders regarding the impacts to home infusion from the Centers for Medicare and Medicaid Services’ (CMS) interim final rule published in response to the COVID-19 public health emergency.
Read more

March 30, 2020 
NHIA Issues COVID-19 Related Recommendations to Commercial Insurers Read recommendations.
Read more

Enrollment is Open for the new 2020 Benchmarking Pilot: Status at Discharge and 30-Day Hospital Readmission
Read more
March 18, 2020

NHIA, key stakeholders urge Congress to prioritize home-based care in coronavirus legislation
Read the Release
Read House Letter
Read Senate Letter
Read HHS Letter

March 18, 2020

NHIA cancels 2020 Annual Conference following public health concerns
Read the release
March 12, 2020

Congress introduces legislation for Medicare Part B home infusion fix
Read the release
March 12, 2020

NHIA welcomes Brightree to Future of Infusion Advisory Council
Read the release
Feb 20, 2020

NHIA and 250+ stakeholders urge CMS to overhaul home infusion rules
Read the press release
Feb 14, 2020

NHIA partners with NASP to Offer Certified Specialty Pharmacist Exam Preparatory Course at 2020 Annual Conference Read the release.

Read the press release

Feb 10, 2020

NHIA Submits Comments on CMS solicitation on Scope of Practice.

Read the comments

Jan 21, 2020

NHIA Submits Comments on Proposed Rulemaking for Stark Law and Anti-Kickback Statue
Read the comments
Jan 1, 2020

NHIF announces Q2 2019 home infusion industry patient satisfaction benchmarks
Read the open access report
Dec 30, 2019

NHIA comments on the use of pharmacy technicians in sterile compounding
Read the statement

Dec 18, 2019

NHIA Submits Comments in Response to “Cures 2.0” RFI
Read the comments
Dec 16, 2019

NHIA Submits Comments to CMS on Home Health Final Rule
Read the comments
Download template to submit your comments
Dec 11, 2019

NHIA applauds Senator Isakson for leadership on home infusion
Read the statement
Dec 4, 2019

The National Home Infusion Foundation (NHIF) has announced a public comment period for the next phase of its Benchmarking Program that includes two new metrics to launch in 2020.

NHIA members are encouraged to review the draft benchmarking participation guides for collecting industry-wide outcome data for 30-day Rehospitalizations, and the Status at Discharge for patients receiving infusions in the home or suite setting. A revised definition for the Discharge Reasons is also proposed to support data collection for the new benchmarking metrics. Deadline to submit comment is December 31. Send comments to nhifdata@nhia.org.
See all documents
Dec 3, 2019

NHIA announces 2020 Annual Conference in Denver
Read the release
Nov 15, 2019

Important Facts about Parenteral Selenium (Selenious Acid)
Read the fact sheet
Nov 6, 2019

NHIA expresses disappointment on CMS home health payment rule
Read the Statement
Read the Summary
Stream the Webinar

Nov 1, 2019

White House Releases Proposed Rules on Medicare Value-Based Arrangements
Read the letter
Oct 23, 2019

NHIA calls on American Reagent to Revise Pricing/Stability for Selenious Acid
Read the letter
Oct 4, 2019

NHIA members share insight on home and specialty infusion on Capitol Hill
Read the release
Oct 2, 2019

NHIA submits comments to CMS on ESRD rule urging them not to include E0781 in the “master list”

Read Comments

September 27, 2019

NHIF announces first-ever home infusion industry patient satisfaction benchmarks
Read the open access report
Sept 12, 2019

NHIA and IACP announce co-location of 2020 annual conferences in Denver
Read the release
Sept 10, 2019

NHIA Submits Comments on CMS’ Proposed CY 2020 Home Health Payment Rule
Read Comments
Sept 9, 2019

NHIA Submits Comments on Administration’s Patients Over Paperwork Initiative
Read Comments
Aug 20, 2019

NHIA Submits Comments to CMS on Changes to Part B DMEPOS Ig Policy
Read Comments
Aug 20, 2019

NHIA congratulates Option Care and BioScrip on successful merger
Read Media Statement
Aug 8, 2019

NHIA 2020 Annual Conference registration now open
View Website
Aug 5, 2019

NHIA Denounces CMS Proposed Home Infusion Rule
Read the Press Release

Read a Summary of the Proposed Rule

July 16, 2019

NHIA Position Paper: Home Infusion Reimbursement Must Reflect Essential Specialized Pharmacy Professional Services Read the Position Paper

Read the Position Paper

May 21, 2019

NHIA Takes Legal Action Against CMS’ Transitional Payment

Read the complaint
Read the press release
Register for the Webinar

Feb. 15, 2019

HHS Proposed Rule Takes Aim at Drug Rebates from Manufacturers to Health Plans/PBMs, Proposes Safe Harbors to Pass Savings to Consumers and Protect Some Manufacturer-PBM Payments

Read more

Feb. 1, 2019

NHIA Comments on CMS proposal to modernize Part D and Medicare Advantage to lower drug prices

Read more

Jan. 25, 2019

Charron Named COO; Noyes Promoted to Senior Vice President, Reimbursement Policy

Read more

Jan. 9, 2019

NHIA Submits Comments to CMS on Home infusion Transitional Payment

See NHIA’s Comments

Dec. 27, 2018

NHIA Accepting Nominations for Gene Graves Award

Submit nomination

Dec. 13, 2018

NHIA Submits Comments to FDA on Draft MOU Addressing Certain Distributions of Compounded Drug Products Between States and FDA

Read NHIA comments

Dec. 10, 2018

Talk Infusion Webinar — Home Infusion Transitional Payment: Staying the Course

Access recording

Dec. 4, 2018

NHIA To Submit Comments on Draft Memorandum of Understanding Addressing Certain Distributions of Compounded Drug Products Between States and the FDA; Comment Deadline is Monday, December 10

Read NHIA comments

Dec. 7, 2018

CMS Issues Details on Transitional Payment to Begin January 1, 2019. Access MLN Matters MM10836 – Temporary Transitional Payment for Home Infusion Therapy Services for CYs 2019 and 2020

Read announcement

Dec. 4, 2018

Sullivan Named NHIA President and CEO
Read announcement

Oct. 5, 2018

Letter to CMS Administrator Seema Verma

Sept. 28, 2018

House Letter on CMS Proposed RuleSeptember 14, 2021

NHIA and 20+ Organizations Sign Joint Letter To Congress To Support Home Infusion Legislation

NHIA submitted comments to the Centers for Medicare and Medicaid Services (CMS) on a proposed rule that outlined CY 2022 payment policies under the Physician Fee Schedule and other changes to Medicare Part B payment polices.